Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

XFOR X4 Pharmaceuticals Inc

0,798

0,218 (37,59%)

27 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

X4 Pharmaceuticals (NASDAQ:XFOR)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more X4 Pharmaceuticals Charts.

X4 Pharmaceuticals (NASDAQ:XFOR)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more X4 Pharmaceuticals Charts.

News X4 Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 19 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 13 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 13 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 8 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 8 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 8 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 8 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 8 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 11 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 9 September 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere X4 Pharmaceuticals Inc News-Artikel

L&G US ESG Exclusions Pa...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen